Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
International Women’s Day
On International Women’s Day, we celebrate all women in science and health. The OraSure family of companies, including Diversigen, DNA Genotek, and Novosanis, are proud to include a diverse, and international team of women, across various roles and divisions. For this years' blog, we honor all the...
EACR Conference Liquid Biopsies
Novosanis will be present at the EACR Conference on Liquid Biopsies in Bergamo, Italy between May 24-26 2022. Our team is excited to participate in latest scientific discussions on the role of liquid biopsies in cancer research. We will also share our work on the potential of urine as liquid biopsy...